Terocin Patch
NDC Package 68788-9555-1
Package Information
Terocin (lidocaine, menthol) patches is adults and childred 12 years and over: Apply patch to affected area 1 to 2 times daily or as directed.Instructions for use:1.Clean and dry the affected area2.Open pouch and remove one patch3.Remove any protective film and apply directly to affected area of pain4.Wash hands with soap and water after applying patch5.Reseal pouch containing unused patches after each use. This formulation utilizes a patch delivery system. Marketed by Preferred Pharmaceuticals, Inc., this product is identified by NDC 68788-9555 and is authorized under FDA application part348.
Identification & Billing
- RxCUI: 1428948 - lidocaine 4 % / menthol 4 % Medicated Patch
- RxCUI: 1428948 - lidocaine 0.04 MG/MG / menthol 0.04 MG/MG Medicated Patch
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68788 - Preferred Pharmaceuticals, Inc.
- 68788-9555 - Terocin
- 68788-9555-1 - 2 POUCH in 1 BOX / 5 PATCH in 1 POUCH
- 68788-9555 - Terocin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68788-9555-1 identifies a specific commercial package of 2 pouch in 1 box / 5 patch in 1 pouch of Terocin, a human over the counter drug labeled by Preferred Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 2 billable units per package. This patch is formulated for topical use and contains lidocaine; menthol, unspecified form as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Preferred Pharmaceuticals, Inc. on September 23, 2013. The current certification is valid through December 31, 2026.
How is this Preferred Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68788955501. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.